posted on 2018-05-16, 00:00authored byRosana Leiva, Matthew B. Phillips, Andreea L. Turcu, Esther Gratacòs-Batlle, Lara León-García, Francesc X. Sureda, David Soto, Jon W. Johnson, Santiago Vázquez
This
work reports the synthesis and pharmacological and electrophysiological
evaluation of new N-methyl-d-aspartic acid
receptor (NMDAR) channel blocking antagonists featuring polycyclic
scaffolds. Changes in the chemical structure modulate the potency
and voltage dependence of inhibition. Two of the new antagonists display
properties comparable to those of memantine, a clinically approved
NMDAR antagonist.